Fluticasone furoate/vilanterol versus fluticasone propionate in patients with asthma and exercise-induced bronchoconstriction

References

• Ostrom NK, Taveras H, Iverson H, Pearlman DS. Novel albuterol multidose dry powder inhaler in patients with exercise-induced bronchoconstriction: A single-dose, double-blind, randomized, 2-way crossover study. Respir Med 2015;109:1410–1415.
   PubMed Web of Science ®Google Scholar
• Bonini M, P P. Exercise-induced bronchoconstriction: new evidence in pathogenesis, diagnosis and treatment. Asthma Res Pract 2015;1:2. doi:10.1186/s40733-015-0004-4
   PubMedGoogle Scholar
• Asthma and Allergy Foundation of America. What causes or triggers asthma? Available from: http://www.aafa.org/page/asthma-triggers-causes.aspx.
   Google Scholar
• Parsons JP, Hallstrand TS, Mastronarde JG, Kaminsky DA, Rundell KW, Hull JH, Storms WW. An Official American Thoracic Society clinical practice guideline: exercise-induced bronchoconstriction. Am J Respir Crit Care Med 2013;187:1016–1027.
   PubMed Web of Science ®Google Scholar
• Jayasinghe H, Kopsaftis Z, Carson K. Asthma bronchiale and exercise-induced bronchoconstriction. Respiration 2015;89:505–512. doi:10.1159/000433559
   PubMed Web of Science ®Google Scholar
• British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. 2016. Available from: https://www.brit-thoracic.org.uk/document-library/clinical-information/asthma/btssign-asthma-guideline-2016/.
   Google Scholar
• Duong ML, Subbarao P, Adelroth E, Obminski G, Strinich T, Inman M, Pedersen S. Sputum eosinophils and the response of exercise-induced bronchoconstriction to corticosteroid in asthma. Chest 2008;133:404–411.
   PubMed Web of Science ®Google Scholar
• Price DB, Colice G, Israel E, Roche N, Postma DS, Guilbert TW, et al. Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler. ERJ Open Res 2016;2:00106–02015, doi:10.1183/23120541.00106-2015
   PubMedGoogle Scholar
• Aalbers R, Vogelmeier C, Kuna P. Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention. Respir Med 2016;111:1–7.
   PubMed Web of Science ®Google Scholar
• Chauhan BF, Ducharme FM. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. Cochrane Database Syst Rev 2014;CD003137,. doi:10.1002/14651858
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2018. Available from: http://ginasthma.org/2018-gina-report-global-strategy-for-asthma-management-and-prevention/.
   Google Scholar
• Weiler JM, Brannan JD, Randolph CC, Hallstrand TS, Parsons J, Silvers W, Storms W, et al. Exercise-induced bronchoconstriction update-2016. J. Allergy Clin Immunol 2016;138:1292–1295.
   PubMed Web of Science ®Google Scholar
• Weiler JM, Nathan RA, Rupp NT, Kalberg CJ, Emmett A, Dorinsky PM. Effect of fluticasone/salmeterol via a single device on exercise-induced bronchospasm in patients with persistent asthma. Ann Allergy Asthma Immunol 2005;94:65–72. doi:10.1016/S1081-1206(10)61288-4
   PubMed Web of Science ®Google Scholar
• Pearlman D, Qaqundah P, Matz J, Yancey SW, Stempel DA, Ortega HG. Fluticasone propionate/salmeterol and exercise-induced asthma in children with persistent asthma. Pediatr Pulmonol 2009;44:429–435.
   PubMed Web of Science ®Google Scholar
• Murray JJ, Waitkus-Edwards KR, Yancey SW. Evaluation of fluticasone propionate and fluticasone propionate/salmeterol combination on exercise in pediatric and adolescent patients with asthma. Open Respir Med J 2011;5:11–18. doi:10.2174/1874306401105010011
   PubMedGoogle Scholar
• Braithwaite I, Williams M, Power S, Pilcher J, Weatherall M, Baines A, Moynihan J, et al. Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma. Respir Med 2016;119:115–121. doi:10.1016/j.rmed.2016.09.006
   PubMed Web of Science ®Google Scholar
• Hofstra WB, Neijens HJ, Duiverman EJ, Kouwenberg JM, Mulder PGH, Kuethe MC, Sterk PJ, et al. Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma. Pediatr Pulmonol 2000;29:415–423. doi:10.1002/(SICI)1099-0496(200006)29:6<415::AID-PPUL1>3.0.CO;2-7
   PubMed Web of Science ®Google Scholar
• National Institutes of Health (NIH). National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. 2007. Available from: https://www.nhlbi.nih.gov/files/docs/guidelines/asthsumm.pdf.
   Google Scholar
• Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012;40:1324–1343.
   PubMed Web of Science ®Google Scholar
• Juniper EF, Svensson K, Mörk AC, Ståhl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 2005;99:553–558.
   PubMed Web of Science ®Google Scholar
• Subbarao P, Duong M, Adelroth E, Otis J, Obminski G, Inman M, Pedersen S, et al. Effect of ciclesonide dose and duration of therapy on exercise-induced bronchoconstriction in patients with asthma. J Allergy Clin Immunol 2006;117:1008–1013.
   PubMed Web of Science ®Google Scholar
• Aziz I, Tan KS, Hall IP, Devlin MM, Lipworth BJ. Subsensitivity to bronchoprotection against adenosine monophosphate challenge following regular once-daily formoterol. Eur Respir J 1998;12:580–584. doi:10.1183/09031936.98.12030580
   PubMed Web of Science ®Google Scholar
• Bhagat R, Kalra S, Swystun VA, Cockcroft DW. Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest 1995;108:1235–1239.
   PubMed Web of Science ®Google Scholar
• Drotar DE, Davis EE, Cockcroft DW. Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment. Ann Allergy Asthma Immunol 1998;80:31–34. doi:10.1016/S1081-1206(10)62935-3
   PubMed Web of Science ®Google Scholar
• Giannini D, Di Franco A, Bacci E, Dente FL, Bartoli ML, Vagaggini B, Paggiaro P. Tolerance to the protective effect of salmeterol on allergen challenge can be partially restored by the withdrawal of salmeterol regular treatment. Chest 2001;119:1671–1675. doi:10.1378/chest.119.6.1671
   PubMed Web of Science ®Google Scholar
• Rosethorne EM, Bradley ME, Kent TC, Charlton SJ. Functional desensitization of the β 2 adrenoceptor is not dependent on agonist efficacy. Pharmacol Res Perspect 2015;3:e00101
   PubMed Web of Science ®Google Scholar
• Bonini M, Permaul P, Kulkarni T, Kazani S, Segal A, Sorkness CA, Wechsler ME, Israel E. Loss of salmeterol bronchoprotection against exercise in relation to ADRB2 Arg16Gly polymorphism and exhaled nitric oxide. Am J Respir Crit Care Med 2013;188:1407–1412.
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Ormiston TM, Salpeter EE. Meta-analysis: respiratory tolerance to regular beta2-agonist use in patients with asthma. Ann Intern Med 2004;140:802–813.
   PubMed Web of Science ®Google Scholar
• Anderson SD, Pearlman DS, Rundell KW, Perry CP, Boushey H, Sorkness CA. Reproducibility of the airway response to an exercise protocol standardized for intensity, duration, and inspired air conditions, in subjects with symptoms suggestive of asthma. Respir Res 2010;11:120. doi:10.1186/1465-9921-11-120
   PubMed Web of Science ®Google Scholar
• Chan HCS, Filipek S, Yuan S. The principles of ligand specificity on beta-2-adrenergic receptor. Sci Rep 2016;6:34736
   PubMed Web of Science ®Google Scholar
• Kersten ET, Driessen JM, van Leeuwen JC, Thio BJ. Pilot study: The effect of reducing treatment on exercise induced bronchoconstriction. Pediatr Pulmonol 2010;45:927–933. doi:10.1002/ppul.21278
   PubMed Web of Science ®Google Scholar